Prostate Cancer Working Group 3 (PCWG3) Criteria in Clinical Trials

April 16, 2020 | Press Releases

Dr. Alicia Morgans (Northwestern University Feinberg School of Medicine) welcomes PCCTC Medical Director Dr. Michael Morris (Memorial Sloan Kettering Cancer Center) and Dr. Lawrence Schwartz (Columbia University Medical Center, New York-Presbyterian Hospital) to discuss the Prostate Cancer Working Group (PCWG3) criteria as a refresher for investigators who are treating men with prostate cancer in clinical trials. For full transcript of the talk, including slides, visit UroToday.

Committed to world-class science!

Our services translate scientific discoveries into improved standards of care, ensuring efficient trial selection, reporting, site management, clinical operations and data analyses.